Pure Biologics S.A. (PQB.SG)

1.6780 +0.0120 (+0.72%) At close: 05:14PM CEST

Pure Biologics S.A.

ul. Dunska 11
Wroclaw 54-427
Poland
48 795 61 18 11
https://purebiologics.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 96

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Filip Jelen M.B.A., Ph.D.	Co-founder & President of the Management Board	N/A	N/A	N/A
Mr. Romuald Apollo Harwas	Vice President of the Management Board & CFO	N/A	N/A	N/A
Dr. Pieter Spee	Vice President of the Management Board & Chief Scientific Officer	N/A	N/A	N/A
Ms. Marta Wawrzyniak M.B.A.	Chief Operating Officer	N/A	N/A	N/A
Ms. Martyna Koj	Director of the Company Office & Investor Relations Representative	N/A	N/A	N/A
Ms. Marta Rot	Head of HR	N/A	N/A	N/A
Mr. Przemyslaw Dudek	Head of Information Technology	N/A	N/A	N/A
Dr. Ewelina Swiderek	Head of Projects Portfolio	N/A	N/A	N/A
Mr. Maciej Mazurek M.B.A.	Director of Science & Innovation	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Pure Biologics S.A., a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified aptamers for therapeutic and diagnostic use. It also engages in the development of non-systemic therapies for use in treating patients suffering from neurological autoimmune disorders, including neuromyelitis optica and myasthenia gravis; and provides contract research for pharmaceutical and biotechnology companies. Pure Biologics S.A. was incorporated in 2010 and is headquartered in Wroclaw, Poland.

Corporate governance

Pure Biologics S.A.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.